Form D · Other Health Care
Hemanext Inc.
Lexington, MA · CIK 0001305849
Offering snapshot reported Aug 5, 2025 · SEC filing
- Reported sold
- $20M Offering amount: $24M
- Investors reported
- 29 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 18, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 5, 2025 | Initial | $19,978,442 | No comparison | 29 | SEC filing |
| Jul 31, 2025 | Initial | $21,714,277 | No comparison | 51 | SEC filing |
| Jan 8, 2024 | Initial | $5,005,000 | No comparison | 10 | SEC filing |
| Nov 8, 2023 | Initial | $11,285,000 | No comparison | 20 | SEC filing |
| Feb 7, 2023 | Initial | $13,248,996 | No comparison | 38 | SEC filing |
| Oct 15, 2021 | Amendment | $39,636,597 | $18,416,597vs Oct 23, 2020 | 39 | SEC filing |
| Oct 23, 2020 | Amendment | $21,220,000 | $16,795,000vs Oct 25, 2019 | 10 | SEC filing |
| Oct 25, 2019 | Initial | $4,425,000 | No comparison | 7 | SEC filing |
| Oct 26, 2018 | Amendment | $8,750,000 | $6,750,000vs Feb 6, 2018 | 6 | SEC filing |
| Feb 6, 2018 | Initial | $2,000,000 | No comparison | 2 | SEC filing |
| Dec 19, 2017 | Initial | $2,700,000 | No comparison | 6 | SEC filing |
| Dec 20, 2016 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Dec 16, 2013 | Initial | $12,281,936 | No comparison | 3 | SEC filing |
| Apr 19, 2006 | Paper | Not reported | No comparison | Not reported |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $41.3K
- Finders' fees
- $0
- Form D file number
- 021-553719
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Octavian AG | None |
Source: Form D, filed Aug 5, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Eduardo Avaya | Director |
| Eduardo Avayu | Director |
| Joseph B. Barrett | Executive |
| Michael Bavonese | Executive |
| Jill Buckley | Executive |
| Martin A. Cannon | Director, Executive |
| Guy Cogan | Director |
| Rafael Cordero | Executive |
| Geoffrey Crouse | Director |
| Laura Daniels | Executive |
| Kimberly Dorsch | Executive |
| Andrew Dunham | Director, Executive |
| Steve Eckert | Director |
| Stephen A. Eckert | Director |
| Joseph Grogan | Director |
| Robert Haime | Executive |
| David Herman | Director |
| Daan Kok | Executive |
| Ismail Kola | Director |
| Lynn Mallett | Executive |
| Alex Marichal | Executive |
| Paul M. Ness | Director |
| Eric J. Newman | Executive |
| Laurel Omert | Executive |
| William Patrick O'neill | Director |
| Philip M. Pead | Director |
| Richard Perle | Director |
| Michael David Testa | Director |
| David Testa | Director |
| Peter Testa | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
99 Hayden Avenue, Building B Suite 620
Lexington, MA, 02421
Lexington, MA, 02421